Literature DB >> 27761778

Antibiotic Resistance in Pediatric Urinary Tract Infections.

Jeremy S Stultz1, Christopher D Doern2, Emily Godbout3.   

Abstract

Urinary tract infections (UTIs) are a common problem in pediatric patients. Resistance to common antibiotic agents appears to be increasing over time, although resistance rates may vary based on geographic region or country. Prior antibiotic exposure is a pertinent risk factor for acquiring resistant organisms during a first UTI and recurrent UTI. Judicious prescribing of antibiotics for common pediatric conditions is needed to prevent additional resistance from occurring. Complex pediatric patients with histories of hospitalizations, prior antibiotic exposure, and recurrent UTIs are also at high risk for acquiring UTIs due to extended spectrum beta-lactamase-producing organisms. Data regarding the impact of in vitro antibiotic susceptibility testing interpretation on UTI treatment outcomes is lacking.

Entities:  

Keywords:  Extended spectrum beta-lactamases; Microbial sensitivity tests; Pediatric; Urinary tract infections

Year:  2016        PMID： 27761778     DOI： 10.1007/s11908-016-0555-4

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


  38 in total

Review 1.  Antibiotics for acute pyelonephritis in children.

Authors:  Yvonne Strohmeier; Elisabeth M Hodson; Narelle S Willis; Angela C Webster; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2014-07-28

2.  Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis.

Authors:  Shawn L Ralston; Allan S Lieberthal; H Cody Meissner; Brian K Alverson; Jill E Baley; Anne M Gadomski; David W Johnson; Michael J Light; Nizar F Maraqa; Eneida A Mendonca; Kieran J Phelan; Joseph J Zorc; Danette Stanko-Lopp; Mark A Brown; Ian Nathanson; Elizabeth Rosenblum; Stephen Sayles; Sinsi Hernandez-Cancio
Journal:  Pediatrics       Date:  2014-11       Impact factor: 7.124

3.  Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.

Authors:  D A Talan; W E Stamm; T M Hooton; G J Moran; T Burke; A Iravani; J Reuning-Scherer; D A Church
Journal:  JAMA       Date:  2000 Mar 22-29       Impact factor: 56.272

4.  National ambulatory antibiotic prescribing patterns for pediatric urinary tract infection, 1998-2007.

Authors:  Hillary L Copp; Daniel J Shapiro; Adam L Hersh
Journal:  Pediatrics       Date:  2011-05-09       Impact factor: 7.124

5.  Antimicrobial Resistance and Urinary Tract Infection Recurrence.

Authors:  Caleb P Nelson; Alejandro Hoberman; Nader Shaikh; Ron Keren; Ranjiv Mathews; Saul P Greenfield; Tej K Mattoo; Nathan Gotman; Anastasia Ivanova; Marva Moxey-Mims; Myra A Carpenter; Russell W Chesney
Journal:  Pediatrics       Date:  2016-03-11       Impact factor: 7.124

6.  Variation in antibiotic susceptibility of uropathogens by age among ambulatory pediatric patients.

Authors:  Jessina C McGregor; Yennie Quach; David T Bearden; David H Smith; Susan E Sharp; Judith A Guzman-Cottrill
Journal:  J Pediatr Nurs       Date:  2013-09-30       Impact factor: 2.145

7.  Urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and nonproducing bacteria: a comparative study.

Authors:  Noam Dayan; Husein Dabbah; Irith Weissman; Ibrahim Aga; Lea Even; Daniel Glikman
Journal:  J Pediatr       Date:  2013-08-03       Impact factor: 4.406

8.  Antibiotic resistance patterns of outpatient pediatric urinary tract infections.

Authors:  Rachel S Edlin; Daniel J Shapiro; Adam L Hersh; Hillary L Copp
Journal:  J Urol       Date:  2013-01-28       Impact factor: 7.450

9.  Antimicrobial resistance among Escherichia coli that cause childhood community-acquired urinary tract infections in Northern Italy.

Authors:  Alessandra Caracciolo; Alberto Bettinelli; Claudio Bonato; Clementina Isimbaldi; Alessandro Tagliabue; Laura Longoni; Mario G Bianchetti
Journal:  Ital J Pediatr       Date:  2011-01-06       Impact factor: 2.638

10.  Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.

Authors:  Seung Beom Han; Sung Chul Lee; Soo Young Lee; Dae Chul Jeong; Jin Han Kang
Journal:  BMC Infect Dis       Date:  2015-10-13       Impact factor: 3.090
View more
  4 in total

1.  High rates of multidrug resistance among uropathogenic Escherichia coli in children and analyses of ESBL producers from Nepal.

Authors:  Narayan Prasad Parajuli; Pooja Maharjan; Hridaya Parajuli; Govardhan Joshi; Deliya Paudel; Sujan Sayami; Puspa Raj Khanal
Journal:  Antimicrob Resist Infect Control       Date:  2017-01-11       Impact factor: 4.887

2.  Distribution of virulence genes and their association with antimicrobial resistance among uropathogenic Escherichia coli isolates from Iranian patients.

Authors:  Yalda Malekzadegan; Reza Khashei; Hadi Sedigh Ebrahim-Saraie; Zahra Jahanabadi
Journal:  BMC Infect Dis       Date:  2018-11-15       Impact factor: 3.090

3.  Phylogenetic Group/Subgroups Distributions, Virulence Factors, and Antimicrobial Susceptibility of Escherichia coli Strains from Urinary Tract Infections in Hatay.

Authors:  Ebru Şebnem Yılmaz; Özkan Aslantaş
Journal:  Rev Soc Bras Med Trop       Date:  2020-02-07       Impact factor: 1.581

4.  Co-Amoxiclav as empiric treatment of UTI in children: importance of surveillance in ensuring optimal empiric treatment choice.

Authors:  James Trayer; Michael Horgan; Anna-Rose Prior; Martin Ryan; Montasser Nadeem
Journal:  Int J Clin Pharm       Date:  2021-08-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.